These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21695548)

  • 1. Can we prevent or treat renal dysfunction in chronic heart failure?
    Dobre D; Rossignol P; Metra M; Zannad F
    Heart Fail Rev; 2012 Mar; 17(2):283-90. PubMed ID: 21695548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we prevent or treat renal dysfunction in acute heart failure?
    Lazzarini V; Bettari L; Bugatti S; Carubelli V; Lombardi C; Metra M; Dei Cas L
    Heart Fail Rev; 2012 Mar; 17(2):291-303. PubMed ID: 21556945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment.
    Reina-Couto M; Afonso J; Carvalho J; Morgado L; Ronchi FA; de Oliveira Leite AP; Dias CC; Casarini DE; Bettencourt P; Albino-Teixeira A; Morato M; Sousa T
    Biomed Pharmacother; 2021 Jan; 133():110938. PubMed ID: 33171402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.
    Silverberg DS; Wexler D; Iaina A; Steinbruch S; Wollman Y; Schwartz D
    Int Urol Nephrol; 2006; 38(2):295-310. PubMed ID: 16868702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal adaptation to the failing heart. Avoiding a 'therapeutic misadventure'.
    Riley DJ; Weir M; Bakris GL
    Postgrad Med; 1994 Jun; 95(8):153-6. PubMed ID: 8202420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
    Werner C; Pöss J; Böhm M
    Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology.
    Mewton N; Girerd N; Boffa JJ; Courivaud C; Isnard R; Juillard L; Lamblin N; Legrand M; Logeart D; Mariat C; Meune E; Sabouret P; Sebbag L; Rossignol P
    Arch Cardiovasc Dis; 2020 Oct; 113(10):660-670. PubMed ID: 32660835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of progressive renal dysfunction in chronic heart failure.
    Maxwell AP; Ong HY; Nicholls DP
    Eur J Heart Fail; 2002 Mar; 4(2):125-30. PubMed ID: 11959039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
    Svensson M; Gustafsson F; Galatius S; Hildebrandt PR; Atar D
    J Card Fail; 2004 Aug; 10(4):297-303. PubMed ID: 15309695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal dysfunction in heart failure.
    Cole RT; Masoumi A; Triposkiadis F; Giamouzis G; Georgiopoulou V; Kalogeropoulos A; Butler J
    Med Clin North Am; 2012 Sep; 96(5):955-74. PubMed ID: 22980058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure and chronic kidney disease: should we use spironolactone?
    Agrawal S; Agrawal N; Garg J; Mohandas R; Gupta T; Segal M
    Am J Med Sci; 2015 Aug; 350(2):147-51. PubMed ID: 26086152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.
    Feenstra J; Grobbee DE; Mosterd A; Stricker BH
    Drug Saf; 1997 Sep; 17(3):166-80. PubMed ID: 9306052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld.
    Schranz D; Voelkel NF
    Eur J Pediatr; 2016 Apr; 175(4):445-55. PubMed ID: 26895877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between congestive heart failure and chronic renal disease.
    Silverberg D; Wexler D; Blum M; Schwartz D; Iaina A
    Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):163-70. PubMed ID: 15202610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal dysfunction is associated with shorter telomere length in heart failure.
    Wong LS; van der Harst P; de Boer RA; Codd V; Huzen J; Samani NJ; Hillege HL; Voors AA; van Gilst WH; Jaarsma T; van Veldhuisen DJ
    Clin Res Cardiol; 2009 Oct; 98(10):629-34. PubMed ID: 19603133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.